Fluorescence immunoassay test for cardiac marker detection. Used for assessment of myocardial injury and cardiac risk evaluation.
Manufactured by
Xiamen Biotime Biotechnology Co., Ltd.
China
Xiamen Biotime Biotechnology Co., Ltd. is a national high-tech enterprise specializing in R&D, manufacturing, and sales of in-vitro diagnostic reagents and instruments. Recognized as a National Specialized and Innovative "Little Giant" Enterprise and listed among China's Top 500 Private Manufacturing Enterprises. Technology platforms include chemiluminescence, molecular diagnostics, chromatography, mass spectrometry, dry chemistry, electrochemistry, fluorescence immunoassay, and colloidal gold. Products are exported to over 60 countries and regions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SJK Global LLC
United States · 1 relevant product
Xenta Biomedical Science Co.,Ltd
China · 1 relevant product
Healgen Scientific LLC
United States · 2 relevant products
66 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 97 closest product alternatives
SJK Global LLC · United States
Fluorescence-based immunoassay technology for point-of-care applications using the LTRIC-600 benchtop analyzer. FIA provides rapid results with sensitive detection capabilities.
Xenta Biomedical Science Co.,Ltd · China
A dry-phase fluorescent immunoassay detection platform for in vitro diagnostic testing. The analyzer provides rapid results with high sensitivity and is designed for point-of-care applications across multiple clinical disciplines.
Healgen Scientific LLC · United States
CLIA-waived rapid immunofluorescence assay (FIA) test kit for qualitative detection of fentanyl in oral fluid specimens. Enables point-of-care screening for opioid use in clinical, workplace, and forensic settings with 510(k) clearance. Results available within minutes without laboratory instrumentation.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products